HomeFRX • TSE
add
Fennec Pharmaceuticals Inc
Previous close
$10.54
Year range
$7.02 - $13.83
Market cap
356.23M CAD
Avg Volume
1.23K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 12.46M | 78.69% |
Operating expense | 11.99M | 10.83% |
Net income | -638.00K | 88.88% |
Net profit margin | -5.12 | 93.77% |
Earnings per share | -0.03 | 90.41% |
EBITDA | -163.00K | 96.85% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 21.95M | -45.57% |
Total assets | 49.26M | -16.39% |
Total liabilities | 53.75M | -16.13% |
Total equity | -4.49M | — |
Shares outstanding | 28.12M | — |
Price to book | -65.88 | — |
Return on assets | -1.00% | — |
Return on capital | -3.53% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -638.00K | 88.88% |
Cash from operations | 1.49M | 167.68% |
Cash from investing | — | — |
Cash from financing | 1.75M | 431.25% |
Net change in cash | 3.24M | 218.58% |
Free cash flow | 1.14M | 230.22% |
About
Founded
1996
Headquarters
Website
Employees
32
